• Explore /
  • Poster
  • / Halo 110-101: Early safety results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + cisplatin (C) + gemcitabine (G) ± atezolizumab (ATZ) in patients (pts) with locally advanced or metastatic cholangiocarcinoma (CCA) and gallbladder cancer (GBC).

Halo 110-101: Early safety results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + cisplatin (C) + gemcitabine (G) ± atezolizumab (ATZ) in patients (pts) with locally advanced or metastatic cholangiocarcinoma (CCA) and gallbladder cancer (GBC).

Abstract Poster

Authors

null

Do-Youn Oh

Seoul National University Hospital, Seoul, Korea, Republic of (South)

Do-Youn Oh , Mann Muhsin , Andrea J. Bullock , Ghassan K. Abou-Alfa , Rachna T. Shroff , Darren Sigal , Vincent Chung , J. Randolph Hecht , Wilson Wu , Mitesh J. Borad

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03267940

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 408)

DOI

10.1200/JCO.2019.37.4_suppl.408

Abstract #

408

Poster Bd #

M8

Abstract Disclosures

Similar Posters

First Author: Mitesh J. Borad

First Author: Gang Jin

First Author: Eileen M. O'Reilly

First Author: Miao Wang